nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP3A4—Temozolomide—melanoma	0.221	0.576	CbGbCtD
Letrozole—CYP3A4—Vemurafenib—melanoma	0.121	0.316	CbGbCtD
Letrozole—CYP3A4—Docetaxel—melanoma	0.0416	0.108	CbGbCtD
Letrozole—Bifonazole—CYP17A1—melanoma	0.0101	1	CrCbGaD
Letrozole—Thrombophlebitis—Docetaxel—melanoma	0.0015	0.00256	CcSEcCtD
Letrozole—Hepatitis—Dactinomycin—melanoma	0.0015	0.00255	CcSEcCtD
Letrozole—Flushing—Bleomycin—melanoma	0.00149	0.00254	CcSEcCtD
Letrozole—Body temperature increased—Vemurafenib—melanoma	0.00149	0.00254	CcSEcCtD
Letrozole—Stomatitis—Temozolomide—melanoma	0.00147	0.00251	CcSEcCtD
Letrozole—Urinary tract infection—Temozolomide—melanoma	0.00146	0.0025	CcSEcCtD
Letrozole—Hepatobiliary disease—Temozolomide—melanoma	0.00143	0.00243	CcSEcCtD
Letrozole—Alopecia—Bleomycin—melanoma	0.00142	0.00242	CcSEcCtD
Letrozole—Erythema multiforme—Dactinomycin—melanoma	0.00141	0.00241	CcSEcCtD
Letrozole—Haemoglobin—Carmustine—melanoma	0.00141	0.0024	CcSEcCtD
Letrozole—Haemorrhage—Carmustine—melanoma	0.0014	0.00239	CcSEcCtD
Letrozole—Hypoaesthesia—Carmustine—melanoma	0.00139	0.00238	CcSEcCtD
Letrozole—Hot flush—Docetaxel—melanoma	0.00139	0.00237	CcSEcCtD
Letrozole—Flushing—Dactinomycin—melanoma	0.00139	0.00237	CcSEcCtD
Letrozole—Oedema peripheral—Carmustine—melanoma	0.00138	0.00235	CcSEcCtD
Letrozole—Menopausal symptoms—Docetaxel—melanoma	0.00138	0.00235	CcSEcCtD
Letrozole—Connective tissue disorder—Carmustine—melanoma	0.00138	0.00235	CcSEcCtD
Letrozole—Haemoglobin—Temozolomide—melanoma	0.00136	0.00232	CcSEcCtD
Letrozole—Haemorrhage—Temozolomide—melanoma	0.00135	0.00231	CcSEcCtD
Letrozole—Hepatitis—Temozolomide—melanoma	0.00135	0.00231	CcSEcCtD
Letrozole—Asthenia—Vemurafenib—melanoma	0.00135	0.0023	CcSEcCtD
Letrozole—Hypoaesthesia—Temozolomide—melanoma	0.00135	0.0023	CcSEcCtD
Letrozole—Urinary tract disorder—Temozolomide—melanoma	0.00134	0.00228	CcSEcCtD
Letrozole—Oedema peripheral—Temozolomide—melanoma	0.00133	0.00227	CcSEcCtD
Letrozole—Cardiac failure—Docetaxel—melanoma	0.00133	0.00227	CcSEcCtD
Letrozole—Pruritus—Vemurafenib—melanoma	0.00133	0.00227	CcSEcCtD
Letrozole—Connective tissue disorder—Temozolomide—melanoma	0.00133	0.00227	CcSEcCtD
Letrozole—Lethargy—Docetaxel—melanoma	0.00133	0.00227	CcSEcCtD
Letrozole—Urethral disorder—Temozolomide—melanoma	0.00133	0.00226	CcSEcCtD
Letrozole—Alopecia—Dactinomycin—melanoma	0.00132	0.00226	CcSEcCtD
Letrozole—Eye disorder—Carmustine—melanoma	0.00131	0.00223	CcSEcCtD
Letrozole—Pain in extremity—Docetaxel—melanoma	0.0013	0.00222	CcSEcCtD
Letrozole—Flushing—Carmustine—melanoma	0.0013	0.00222	CcSEcCtD
Letrozole—Ill-defined disorder—Bleomycin—melanoma	0.0013	0.00221	CcSEcCtD
Letrozole—Diarrhoea—Vemurafenib—melanoma	0.00129	0.0022	CcSEcCtD
Letrozole—Erythema multiforme—Temozolomide—melanoma	0.00128	0.00218	CcSEcCtD
Letrozole—Eye disorder—Temozolomide—melanoma	0.00126	0.00216	CcSEcCtD
Letrozole—Malaise—Bleomycin—melanoma	0.00126	0.00215	CcSEcCtD
Letrozole—Cardiac disorder—Temozolomide—melanoma	0.00126	0.00214	CcSEcCtD
Letrozole—Flushing—Temozolomide—melanoma	0.00126	0.00214	CcSEcCtD
Letrozole—Leukopenia—Bleomycin—melanoma	0.00125	0.00213	CcSEcCtD
Letrozole—Dizziness—Vemurafenib—melanoma	0.00124	0.00212	CcSEcCtD
Letrozole—Alopecia—Carmustine—melanoma	0.00124	0.00211	CcSEcCtD
Letrozole—Angiopathy—Temozolomide—melanoma	0.00123	0.0021	CcSEcCtD
Letrozole—Mental disorder—Carmustine—melanoma	0.00123	0.00209	CcSEcCtD
Letrozole—Mediastinal disorder—Temozolomide—melanoma	0.00122	0.00208	CcSEcCtD
Letrozole—Malnutrition—Carmustine—melanoma	0.00122	0.00208	CcSEcCtD
Letrozole—Cough—Bleomycin—melanoma	0.00122	0.00208	CcSEcCtD
Letrozole—Ill-defined disorder—Dactinomycin—melanoma	0.00121	0.00206	CcSEcCtD
Letrozole—Vomiting—Vemurafenib—melanoma	0.0012	0.00204	CcSEcCtD
Letrozole—Alopecia—Temozolomide—melanoma	0.0012	0.00204	CcSEcCtD
Letrozole—Dry skin—Docetaxel—melanoma	0.00119	0.00203	CcSEcCtD
Letrozole—Myalgia—Bleomycin—melanoma	0.00119	0.00203	CcSEcCtD
Letrozole—Chest pain—Bleomycin—melanoma	0.00119	0.00203	CcSEcCtD
Letrozole—Rash—Vemurafenib—melanoma	0.00119	0.00202	CcSEcCtD
Letrozole—Mental disorder—Temozolomide—melanoma	0.00119	0.00202	CcSEcCtD
Letrozole—Dermatitis—Vemurafenib—melanoma	0.00118	0.00202	CcSEcCtD
Letrozole—Back pain—Carmustine—melanoma	0.00118	0.00201	CcSEcCtD
Letrozole—Headache—Vemurafenib—melanoma	0.00118	0.00201	CcSEcCtD
Letrozole—Malnutrition—Temozolomide—melanoma	0.00118	0.00201	CcSEcCtD
Letrozole—Breast disorder—Docetaxel—melanoma	0.00118	0.00201	CcSEcCtD
Letrozole—Discomfort—Bleomycin—melanoma	0.00117	0.002	CcSEcCtD
Letrozole—Malaise—Dactinomycin—melanoma	0.00117	0.002	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00117	0.002	CcSEcCtD
Letrozole—Leukopenia—Dactinomycin—melanoma	0.00117	0.00199	CcSEcCtD
Letrozole—Dysgeusia—Temozolomide—melanoma	0.00115	0.00197	CcSEcCtD
Letrozole—Vision blurred—Carmustine—melanoma	0.00115	0.00196	CcSEcCtD
Letrozole—Oedema—Bleomycin—melanoma	0.00114	0.00195	CcSEcCtD
Letrozole—Anaphylactic shock—Bleomycin—melanoma	0.00114	0.00195	CcSEcCtD
Letrozole—Back pain—Temozolomide—melanoma	0.00114	0.00194	CcSEcCtD
Letrozole—Infection—Bleomycin—melanoma	0.00113	0.00193	CcSEcCtD
Letrozole—Nausea—Vemurafenib—melanoma	0.00112	0.00191	CcSEcCtD
Letrozole—Vision blurred—Temozolomide—melanoma	0.00111	0.00189	CcSEcCtD
Letrozole—Myalgia—Dactinomycin—melanoma	0.00111	0.00189	CcSEcCtD
Letrozole—Discomfort—Dactinomycin—melanoma	0.0011	0.00187	CcSEcCtD
Letrozole—Angina pectoris—Docetaxel—melanoma	0.00109	0.00187	CcSEcCtD
Letrozole—Ill-defined disorder—Temozolomide—melanoma	0.00109	0.00187	CcSEcCtD
Letrozole—Leukopenia—Carmustine—melanoma	0.00109	0.00186	CcSEcCtD
Letrozole—Anorexia—Bleomycin—melanoma	0.00109	0.00185	CcSEcCtD
Letrozole—Angioedema—Temozolomide—melanoma	0.00108	0.00184	CcSEcCtD
Letrozole—Oedema—Dactinomycin—melanoma	0.00106	0.00181	CcSEcCtD
Letrozole—Malaise—Temozolomide—melanoma	0.00106	0.00181	CcSEcCtD
Letrozole—Vertigo—Temozolomide—melanoma	0.00106	0.00181	CcSEcCtD
Letrozole—Infection—Dactinomycin—melanoma	0.00106	0.0018	CcSEcCtD
Letrozole—Leukopenia—Temozolomide—melanoma	0.00105	0.0018	CcSEcCtD
Letrozole—Hypertension—Carmustine—melanoma	0.00105	0.0018	CcSEcCtD
Letrozole—Palpitations—Temozolomide—melanoma	0.00104	0.00178	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Bleomycin—melanoma	0.00104	0.00177	CcSEcCtD
Letrozole—Myalgia—Carmustine—melanoma	0.00104	0.00177	CcSEcCtD
Letrozole—Chest pain—Carmustine—melanoma	0.00104	0.00177	CcSEcCtD
Letrozole—Anxiety—Carmustine—melanoma	0.00103	0.00176	CcSEcCtD
Letrozole—Cough—Temozolomide—melanoma	0.00103	0.00175	CcSEcCtD
Letrozole—Paraesthesia—Bleomycin—melanoma	0.00102	0.00175	CcSEcCtD
Letrozole—Weight increased—Docetaxel—melanoma	0.00102	0.00175	CcSEcCtD
Letrozole—Weight decreased—Docetaxel—melanoma	0.00102	0.00174	CcSEcCtD
Letrozole—Hypertension—Temozolomide—melanoma	0.00102	0.00174	CcSEcCtD
Letrozole—Dyspnoea—Bleomycin—melanoma	0.00102	0.00173	CcSEcCtD
Letrozole—Anorexia—Dactinomycin—melanoma	0.00101	0.00173	CcSEcCtD
Letrozole—Arthralgia—Temozolomide—melanoma	0.001	0.00171	CcSEcCtD
Letrozole—Myalgia—Temozolomide—melanoma	0.001	0.00171	CcSEcCtD
Letrozole—Infestation NOS—Docetaxel—melanoma	0.001	0.00171	CcSEcCtD
Letrozole—Infestation—Docetaxel—melanoma	0.001	0.00171	CcSEcCtD
Letrozole—Anxiety—Temozolomide—melanoma	0.000999	0.00171	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000996	0.0017	CcSEcCtD
Letrozole—Oedema—Carmustine—melanoma	0.000994	0.0017	CcSEcCtD
Letrozole—Discomfort—Temozolomide—melanoma	0.00099	0.00169	CcSEcCtD
Letrozole—Decreased appetite—Bleomycin—melanoma	0.00099	0.00169	CcSEcCtD
Letrozole—Infection—Carmustine—melanoma	0.000988	0.00169	CcSEcCtD
Letrozole—Acute coronary syndrome—Docetaxel—melanoma	0.000988	0.00169	CcSEcCtD
Letrozole—Myocardial infarction—Docetaxel—melanoma	0.000982	0.00168	CcSEcCtD
Letrozole—Dry mouth—Temozolomide—melanoma	0.00098	0.00167	CcSEcCtD
Letrozole—Stomatitis—Docetaxel—melanoma	0.000977	0.00167	CcSEcCtD
Letrozole—Pain—Bleomycin—melanoma	0.000974	0.00166	CcSEcCtD
Letrozole—Tachycardia—Carmustine—melanoma	0.000971	0.00166	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000968	0.00165	CcSEcCtD
Letrozole—Anaphylactic shock—Temozolomide—melanoma	0.000961	0.00164	CcSEcCtD
Letrozole—Oedema—Temozolomide—melanoma	0.000961	0.00164	CcSEcCtD
Letrozole—Infection—Temozolomide—melanoma	0.000955	0.00163	CcSEcCtD
Letrozole—Anorexia—Carmustine—melanoma	0.000948	0.00162	CcSEcCtD
Letrozole—Hepatobiliary disease—Docetaxel—melanoma	0.000948	0.00162	CcSEcCtD
Letrozole—Nervous system disorder—Temozolomide—melanoma	0.000942	0.00161	CcSEcCtD
Letrozole—Feeling abnormal—Bleomycin—melanoma	0.000939	0.0016	CcSEcCtD
Letrozole—Skin disorder—Temozolomide—melanoma	0.000933	0.00159	CcSEcCtD
Letrozole—Hyperhidrosis—Temozolomide—melanoma	0.000929	0.00159	CcSEcCtD
Letrozole—Decreased appetite—Dactinomycin—melanoma	0.000924	0.00158	CcSEcCtD
Letrozole—Fatigue—Dactinomycin—melanoma	0.000916	0.00156	CcSEcCtD
Letrozole—Anorexia—Temozolomide—melanoma	0.000916	0.00156	CcSEcCtD
Letrozole—Pain—Dactinomycin—melanoma	0.000909	0.00155	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Carmustine—melanoma	0.000906	0.00155	CcSEcCtD
Letrozole—Urticaria—Bleomycin—melanoma	0.000905	0.00155	CcSEcCtD
Letrozole—Haemoglobin—Docetaxel—melanoma	0.000904	0.00154	CcSEcCtD
Letrozole—Body temperature increased—Bleomycin—melanoma	0.000901	0.00154	CcSEcCtD
Letrozole—Haemorrhage—Docetaxel—melanoma	0.0009	0.00154	CcSEcCtD
Letrozole—Hepatitis—Docetaxel—melanoma	0.0009	0.00154	CcSEcCtD
Letrozole—Insomnia—Carmustine—melanoma	0.000899	0.00154	CcSEcCtD
Letrozole—Hypoaesthesia—Docetaxel—melanoma	0.000895	0.00153	CcSEcCtD
Letrozole—Paraesthesia—Carmustine—melanoma	0.000893	0.00152	CcSEcCtD
Letrozole—Urinary tract disorder—Docetaxel—melanoma	0.000888	0.00152	CcSEcCtD
Letrozole—Dyspnoea—Carmustine—melanoma	0.000887	0.00151	CcSEcCtD
Letrozole—Oedema peripheral—Docetaxel—melanoma	0.000886	0.00151	CcSEcCtD
Letrozole—Somnolence—Carmustine—melanoma	0.000884	0.00151	CcSEcCtD
Letrozole—Connective tissue disorder—Docetaxel—melanoma	0.000884	0.00151	CcSEcCtD
Letrozole—Urethral disorder—Docetaxel—melanoma	0.000882	0.00151	CcSEcCtD
Letrozole—Feeling abnormal—Dactinomycin—melanoma	0.000876	0.00149	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Temozolomide—melanoma	0.000876	0.00149	CcSEcCtD
Letrozole—Insomnia—Temozolomide—melanoma	0.000869	0.00148	CcSEcCtD
Letrozole—Gastrointestinal pain—Dactinomycin—melanoma	0.000869	0.00148	CcSEcCtD
Letrozole—Decreased appetite—Carmustine—melanoma	0.000864	0.00148	CcSEcCtD
Letrozole—Paraesthesia—Temozolomide—melanoma	0.000863	0.00147	CcSEcCtD
Letrozole—Gastrointestinal disorder—Carmustine—melanoma	0.000859	0.00147	CcSEcCtD
Letrozole—Dyspnoea—Temozolomide—melanoma	0.000857	0.00146	CcSEcCtD
Letrozole—Somnolence—Temozolomide—melanoma	0.000854	0.00146	CcSEcCtD
Letrozole—Erythema multiforme—Docetaxel—melanoma	0.000851	0.00145	CcSEcCtD
Letrozole—Pain—Carmustine—melanoma	0.00085	0.00145	CcSEcCtD
Letrozole—Constipation—Carmustine—melanoma	0.00085	0.00145	CcSEcCtD
Letrozole—Dyspepsia—Temozolomide—melanoma	0.000846	0.00144	CcSEcCtD
Letrozole—Eye disorder—Docetaxel—melanoma	0.000841	0.00144	CcSEcCtD
Letrozole—Body temperature increased—Dactinomycin—melanoma	0.00084	0.00143	CcSEcCtD
Letrozole—Abdominal pain—Dactinomycin—melanoma	0.00084	0.00143	CcSEcCtD
Letrozole—Decreased appetite—Temozolomide—melanoma	0.000835	0.00143	CcSEcCtD
Letrozole—Cardiac disorder—Docetaxel—melanoma	0.000835	0.00143	CcSEcCtD
Letrozole—Flushing—Docetaxel—melanoma	0.000835	0.00143	CcSEcCtD
Letrozole—Gastrointestinal disorder—Temozolomide—melanoma	0.00083	0.00142	CcSEcCtD
Letrozole—Fatigue—Temozolomide—melanoma	0.000829	0.00141	CcSEcCtD
Letrozole—Pain—Temozolomide—melanoma	0.000822	0.0014	CcSEcCtD
Letrozole—Constipation—Temozolomide—melanoma	0.000822	0.0014	CcSEcCtD
Letrozole—Feeling abnormal—Carmustine—melanoma	0.000819	0.0014	CcSEcCtD
Letrozole—Asthenia—Bleomycin—melanoma	0.000817	0.0014	CcSEcCtD
Letrozole—Angiopathy—Docetaxel—melanoma	0.000816	0.00139	CcSEcCtD
Letrozole—Gastrointestinal pain—Carmustine—melanoma	0.000813	0.00139	CcSEcCtD
Letrozole—Mediastinal disorder—Docetaxel—melanoma	0.000811	0.00138	CcSEcCtD
Letrozole—Pruritus—Bleomycin—melanoma	0.000806	0.00138	CcSEcCtD
Letrozole—Alopecia—Docetaxel—melanoma	0.000795	0.00136	CcSEcCtD
Letrozole—Feeling abnormal—Temozolomide—melanoma	0.000792	0.00135	CcSEcCtD
Letrozole—Mental disorder—Docetaxel—melanoma	0.000788	0.00135	CcSEcCtD
Letrozole—Body temperature increased—Carmustine—melanoma	0.000786	0.00134	CcSEcCtD
Letrozole—Abdominal pain—Carmustine—melanoma	0.000786	0.00134	CcSEcCtD
Letrozole—Gastrointestinal pain—Temozolomide—melanoma	0.000786	0.00134	CcSEcCtD
Letrozole—Malnutrition—Docetaxel—melanoma	0.000783	0.00134	CcSEcCtD
Letrozole—Dysgeusia—Docetaxel—melanoma	0.000767	0.00131	CcSEcCtD
Letrozole—Urticaria—Temozolomide—melanoma	0.000763	0.0013	CcSEcCtD
Letrozole—Asthenia—Dactinomycin—melanoma	0.000762	0.0013	CcSEcCtD
Letrozole—Body temperature increased—Temozolomide—melanoma	0.00076	0.0013	CcSEcCtD
Letrozole—Abdominal pain—Temozolomide—melanoma	0.00076	0.0013	CcSEcCtD
Letrozole—Back pain—Docetaxel—melanoma	0.000757	0.00129	CcSEcCtD
Letrozole—Diarrhoea—Dactinomycin—melanoma	0.000727	0.00124	CcSEcCtD
Letrozole—Vomiting—Bleomycin—melanoma	0.000724	0.00124	CcSEcCtD
Letrozole—Rash—Bleomycin—melanoma	0.000718	0.00123	CcSEcCtD
Letrozole—Dermatitis—Bleomycin—melanoma	0.000718	0.00123	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—RPP38—melanoma	0.000714	0.0361	CbGpPWpGaD
Letrozole—Asthenia—Carmustine—melanoma	0.000713	0.00122	CcSEcCtD
Letrozole—Leukopenia—Docetaxel—melanoma	0.000701	0.0012	CcSEcCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CUBN—melanoma	0.0007	0.0354	CbGpPWpGaD
Letrozole—Palpitations—Docetaxel—melanoma	0.000692	0.00118	CcSEcCtD
Letrozole—Asthenia—Temozolomide—melanoma	0.000689	0.00118	CcSEcCtD
Letrozole—Cough—Docetaxel—melanoma	0.000683	0.00117	CcSEcCtD
Letrozole—Diarrhoea—Carmustine—melanoma	0.00068	0.00116	CcSEcCtD
Letrozole—Pruritus—Temozolomide—melanoma	0.00068	0.00116	CcSEcCtD
Letrozole—Nausea—Bleomycin—melanoma	0.000677	0.00116	CcSEcCtD
Letrozole—Hypertension—Docetaxel—melanoma	0.000676	0.00115	CcSEcCtD
Letrozole—Vomiting—Dactinomycin—melanoma	0.000676	0.00115	CcSEcCtD
Letrozole—Rash—Dactinomycin—melanoma	0.00067	0.00114	CcSEcCtD
Letrozole—Chest pain—Docetaxel—melanoma	0.000667	0.00114	CcSEcCtD
Letrozole—Myalgia—Docetaxel—melanoma	0.000667	0.00114	CcSEcCtD
Letrozole—Arthralgia—Docetaxel—melanoma	0.000667	0.00114	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000662	0.00113	CcSEcCtD
Letrozole—Dizziness—Carmustine—melanoma	0.000658	0.00112	CcSEcCtD
Letrozole—Diarrhoea—Temozolomide—melanoma	0.000658	0.00112	CcSEcCtD
Letrozole—Dry mouth—Docetaxel—melanoma	0.000652	0.00111	CcSEcCtD
Letrozole—Anaphylactic shock—Docetaxel—melanoma	0.000639	0.00109	CcSEcCtD
Letrozole—Oedema—Docetaxel—melanoma	0.000639	0.00109	CcSEcCtD
Letrozole—Dizziness—Temozolomide—melanoma	0.000635	0.00108	CcSEcCtD
Letrozole—Infection—Docetaxel—melanoma	0.000635	0.00108	CcSEcCtD
Letrozole—Vomiting—Carmustine—melanoma	0.000632	0.00108	CcSEcCtD
Letrozole—Nausea—Dactinomycin—melanoma	0.000631	0.00108	CcSEcCtD
Letrozole—Rash—Carmustine—melanoma	0.000627	0.00107	CcSEcCtD
Letrozole—Nervous system disorder—Docetaxel—melanoma	0.000627	0.00107	CcSEcCtD
Letrozole—Dermatitis—Carmustine—melanoma	0.000626	0.00107	CcSEcCtD
Letrozole—Tachycardia—Docetaxel—melanoma	0.000624	0.00106	CcSEcCtD
Letrozole—Headache—Carmustine—melanoma	0.000623	0.00106	CcSEcCtD
Letrozole—Skin disorder—Docetaxel—melanoma	0.000621	0.00106	CcSEcCtD
Letrozole—Vomiting—Temozolomide—melanoma	0.000611	0.00104	CcSEcCtD
Letrozole—Anorexia—Docetaxel—melanoma	0.000609	0.00104	CcSEcCtD
Letrozole—Rash—Temozolomide—melanoma	0.000606	0.00103	CcSEcCtD
Letrozole—Dermatitis—Temozolomide—melanoma	0.000605	0.00103	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—XRCC3—melanoma	0.000604	0.0305	CbGpPWpGaD
Letrozole—Headache—Temozolomide—melanoma	0.000602	0.00103	CcSEcCtD
Letrozole—Nausea—Carmustine—melanoma	0.000591	0.00101	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—melanoma	0.000582	0.000994	CcSEcCtD
Letrozole—Insomnia—Docetaxel—melanoma	0.000578	0.000987	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—melanoma	0.000574	0.00098	CcSEcCtD
Letrozole—Nausea—Temozolomide—melanoma	0.000571	0.000975	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—melanoma	0.00057	0.000973	CcSEcCtD
Letrozole—Somnolence—Docetaxel—melanoma	0.000568	0.00097	CcSEcCtD
Letrozole—CYP19A1—Endogenous sterols—CYP17A1—melanoma	0.000563	0.0285	CbGpPWpGaD
Letrozole—Dyspepsia—Docetaxel—melanoma	0.000563	0.00096	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—melanoma	0.000556	0.000948	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—melanoma	0.000552	0.000942	CcSEcCtD
Letrozole—Fatigue—Docetaxel—melanoma	0.000551	0.000941	CcSEcCtD
Letrozole—Pain—Docetaxel—melanoma	0.000547	0.000933	CcSEcCtD
Letrozole—Constipation—Docetaxel—melanoma	0.000547	0.000933	CcSEcCtD
Letrozole—Feeling abnormal—Docetaxel—melanoma	0.000527	0.000899	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—melanoma	0.000523	0.000892	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—melanoma	0.000505	0.000863	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—melanoma	0.000505	0.000863	CcSEcCtD
Letrozole—CYP19A1—Endogenous sterols—CYP1B1—melanoma	0.000474	0.024	CbGpPWpGaD
Letrozole—Asthenia—Docetaxel—melanoma	0.000459	0.000783	CcSEcCtD
Letrozole—Pruritus—Docetaxel—melanoma	0.000452	0.000772	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—MLH1—melanoma	0.000451	0.0228	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC39A12—melanoma	0.000442	0.0224	CbGpPWpGaD
Letrozole—Diarrhoea—Docetaxel—melanoma	0.000437	0.000747	CcSEcCtD
Letrozole—Dizziness—Docetaxel—melanoma	0.000423	0.000722	CcSEcCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—melanoma	0.000422	0.0213	CbGpPWpGaD
Letrozole—Vomiting—Docetaxel—melanoma	0.000406	0.000694	CcSEcCtD
Letrozole—CYP2A6—Tamoxifen metabolism—CYP1B1—melanoma	0.000406	0.0205	CbGpPWpGaD
Letrozole—Rash—Docetaxel—melanoma	0.000403	0.000688	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—melanoma	0.000403	0.000687	CcSEcCtD
Letrozole—Headache—Docetaxel—melanoma	0.0004	0.000684	CcSEcCtD
Letrozole—Nausea—Docetaxel—melanoma	0.00038	0.000648	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—melanoma	0.000343	0.0173	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—UGT2B10—melanoma	0.000338	0.0171	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—PRKCA—melanoma	0.000316	0.016	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—VDR—melanoma	0.000299	0.0151	CbGpPWpGaD
Letrozole—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.000296	0.015	CbGpPWpGaD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.000293	0.0148	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—SMUG1—melanoma	0.000285	0.0144	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CYP1B1—melanoma	0.000272	0.0138	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—UGT2B10—melanoma	0.000269	0.0136	CbGpPWpGaD
Letrozole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000265	0.0134	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000261	0.0132	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000258	0.0131	CbGpPWpGaD
Letrozole—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000238	0.0121	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—ATM—melanoma	0.00023	0.0117	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—CDK4—melanoma	0.000229	0.0116	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—melanoma	0.000227	0.0115	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—melanoma	0.000225	0.0114	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00022	0.0111	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000217	0.011	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—EPHA2—melanoma	0.000216	0.0109	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—AKR1B10—melanoma	0.000215	0.0109	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—ERCC2—melanoma	0.000212	0.0107	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000212	0.0107	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000208	0.0105	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000205	0.0104	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC6A11—melanoma	0.000203	0.0103	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—melanoma	0.000197	0.00998	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—melanoma	0.000179	0.00906	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000178	0.00903	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000175	0.00886	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000173	0.00875	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000169	0.00853	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000168	0.00851	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—CDKN1B—melanoma	0.000155	0.00786	CbGpPWpGaD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000149	0.00752	CbGpPWpGaD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.000145	0.00734	CbGpPWpGaD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000145	0.00732	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—melanoma	0.000145	0.00732	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000142	0.00718	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000142	0.00718	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—MAPK3—melanoma	0.00014	0.00708	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—MAPK1—melanoma	0.000133	0.00674	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—MDM2—melanoma	0.000127	0.00644	CbGpPWpGaD
Letrozole—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000122	0.00618	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AURKA—melanoma	0.000118	0.00597	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP17A1—melanoma	0.000113	0.0057	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP17A1—melanoma	0.000111	0.00562	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—UGT2B10—melanoma	9.86e-05	0.00499	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP1B1—melanoma	9.48e-05	0.00479	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—melanoma	9.44e-05	0.00478	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1B1—melanoma	9.35e-05	0.00473	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC5A5—melanoma	9.29e-05	0.0047	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP17A1—melanoma	8.96e-05	0.00453	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	8.74e-05	0.00442	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	8.59e-05	0.00435	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	8.33e-05	0.00421	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	8.31e-05	0.00421	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—E2F1—melanoma	8.14e-05	0.00412	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	7.94e-05	0.00402	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	7.63e-05	0.00386	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—melanoma	7.58e-05	0.00383	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP1B1—melanoma	7.54e-05	0.00382	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	7.53e-05	0.00381	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—RAC1—melanoma	7.39e-05	0.00374	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	7.17e-05	0.00363	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—melanoma	7.15e-05	0.00362	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDK2—melanoma	7.02e-05	0.00355	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HGF—melanoma	6.87e-05	0.00348	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	6.71e-05	0.00339	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ATM—melanoma	6.66e-05	0.00337	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—melanoma	6.63e-05	0.00336	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	6.42e-05	0.00325	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	6.34e-05	0.00321	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ACER3—melanoma	6.32e-05	0.0032	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	6.27e-05	0.00317	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	6.18e-05	0.00313	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—melanoma	5.87e-05	0.00297	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—melanoma	5.81e-05	0.00294	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	5.8e-05	0.00293	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UGT2B10—melanoma	5.78e-05	0.00292	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—RB1—melanoma	5.77e-05	0.00292	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—melanoma	5.75e-05	0.00291	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	5.7e-05	0.00289	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HS3ST5—melanoma	5.37e-05	0.00272	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	5.21e-05	0.00263	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ACER3—melanoma	5.03e-05	0.00254	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—melanoma	4.99e-05	0.00252	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—melanoma	4.92e-05	0.00249	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UGT2B10—melanoma	4.6e-05	0.00233	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—melanoma	4.4e-05	0.00223	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.32e-05	0.00219	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—melanoma	4.28e-05	0.00217	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HS3ST5—melanoma	4.28e-05	0.00216	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—melanoma	4.24e-05	0.00215	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—melanoma	4.13e-05	0.00209	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—melanoma	4.11e-05	0.00208	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLCB4—melanoma	4.07e-05	0.00206	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—FASN—melanoma	4e-05	0.00202	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC6A11—melanoma	3.83e-05	0.00194	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIP4K2A—melanoma	3.83e-05	0.00194	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—melanoma	3.73e-05	0.00189	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTAP—melanoma	3.72e-05	0.00188	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—MDM2—melanoma	3.71e-05	0.00188	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.64e-05	0.00184	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—melanoma	3.43e-05	0.00174	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—melanoma	3.36e-05	0.0017	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—melanoma	3.36e-05	0.0017	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PHGDH—melanoma	3.32e-05	0.00168	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LUM—melanoma	3.32e-05	0.00168	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.29e-05	0.00166	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HPSE—melanoma	3.25e-05	0.00165	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.24e-05	0.00164	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLCB4—melanoma	3.24e-05	0.00164	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CUBN—melanoma	3.19e-05	0.00162	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—melanoma	3.17e-05	0.00161	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SDHD—melanoma	3.08e-05	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CSPG4—melanoma	3.08e-05	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BSG—melanoma	3.08e-05	0.00156	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC6A11—melanoma	3.05e-05	0.00154	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIP4K2A—melanoma	3.05e-05	0.00154	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPAM—melanoma	2.99e-05	0.00151	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTAP—melanoma	2.96e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—melanoma	2.82e-05	0.00143	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.77e-05	0.0014	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.73e-05	0.00138	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PHGDH—melanoma	2.64e-05	0.00134	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LUM—melanoma	2.64e-05	0.00134	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HPSE—melanoma	2.59e-05	0.00131	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CUBN—melanoma	2.54e-05	0.00129	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLA2G6—melanoma	2.54e-05	0.00129	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BSG—melanoma	2.46e-05	0.00124	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SDHD—melanoma	2.46e-05	0.00124	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CSPG4—melanoma	2.46e-05	0.00124	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—melanoma	2.38e-05	0.00121	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPAM—melanoma	2.38e-05	0.0012	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—VCAN—melanoma	2.28e-05	0.00115	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.16e-05	0.00109	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.08e-05	0.00105	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLA2G6—melanoma	2.02e-05	0.00102	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP17A1—melanoma	1.93e-05	0.000974	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.9e-05	0.000961	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.87e-05	0.000948	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACER3—melanoma	1.84e-05	0.000933	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GNA11—melanoma	1.82e-05	0.00092	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—VCAN—melanoma	1.82e-05	0.000919	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—FASN—melanoma	1.78e-05	0.0009	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC5A5—melanoma	1.75e-05	0.000885	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GNAQ—melanoma	1.69e-05	0.000855	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CD44—melanoma	1.69e-05	0.000855	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UGT2B10—melanoma	1.69e-05	0.000853	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.66e-05	0.000837	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.64e-05	0.00083	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1B1—melanoma	1.62e-05	0.00082	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HS3ST5—melanoma	1.57e-05	0.000793	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP17A1—melanoma	1.53e-05	0.000775	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GNA11—melanoma	1.45e-05	0.000732	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.43e-05	0.000724	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FASN—melanoma	1.42e-05	0.000717	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC5A5—melanoma	1.39e-05	0.000705	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GNAQ—melanoma	1.35e-05	0.000681	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CD44—melanoma	1.35e-05	0.000681	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCB1—melanoma	1.33e-05	0.000675	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1B1—melanoma	1.29e-05	0.000653	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PRKCA—melanoma	1.23e-05	0.000621	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ERCC2—melanoma	1.22e-05	0.000616	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLCB4—melanoma	1.19e-05	0.000601	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC6A11—melanoma	1.12e-05	0.000565	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIP4K2A—melanoma	1.12e-05	0.000565	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTAP—melanoma	1.09e-05	0.00055	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCB1—melanoma	1.06e-05	0.000537	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.01e-05	0.00051	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PRKCA—melanoma	9.78e-06	0.000495	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ERCC2—melanoma	9.69e-06	0.000491	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PHGDH—melanoma	9.68e-06	0.00049	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LUM—melanoma	9.68e-06	0.00049	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—melanoma	9.62e-06	0.000487	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPSE—melanoma	9.5e-06	0.00048	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CUBN—melanoma	9.32e-06	0.000472	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—melanoma	9.28e-06	0.00047	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SDHD—melanoma	9e-06	0.000455	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BSG—melanoma	9e-06	0.000455	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CSPG4—melanoma	9e-06	0.000455	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPAM—melanoma	8.72e-06	0.000441	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—melanoma	8.46e-06	0.000428	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—melanoma	8.35e-06	0.000422	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—melanoma	7.66e-06	0.000387	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLA2G6—melanoma	7.41e-06	0.000375	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—melanoma	7.39e-06	0.000374	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—melanoma	7.37e-06	0.000373	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—melanoma	7.3e-06	0.00037	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—melanoma	6.73e-06	0.000341	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—VCAN—melanoma	6.66e-06	0.000337	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—melanoma	6.64e-06	0.000336	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—melanoma	6.37e-06	0.000322	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—melanoma	5.87e-06	0.000297	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—melanoma	5.81e-06	0.000294	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP17A1—melanoma	5.62e-06	0.000284	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GNA11—melanoma	5.31e-06	0.000268	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FASN—melanoma	5.19e-06	0.000263	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC5A5—melanoma	5.11e-06	0.000258	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—melanoma	5.07e-06	0.000256	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CD44—melanoma	4.93e-06	0.00025	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GNAQ—melanoma	4.93e-06	0.00025	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1B1—melanoma	4.73e-06	0.000239	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—melanoma	4.49e-06	0.000227	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCB1—melanoma	3.89e-06	0.000197	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—melanoma	3.67e-06	0.000186	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PRKCA—melanoma	3.58e-06	0.000181	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—melanoma	3.58e-06	0.000181	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ERCC2—melanoma	3.55e-06	0.00018	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—melanoma	2.92e-06	0.000148	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—melanoma	2.81e-06	0.000142	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—melanoma	2.71e-06	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—melanoma	2.47e-06	0.000125	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—melanoma	2.44e-06	0.000123	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—melanoma	2.15e-06	0.000109	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—melanoma	2.13e-06	0.000108	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—melanoma	1.86e-06	9.4e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—melanoma	1.31e-06	6.63e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—melanoma	1.07e-06	5.42e-05	CbGpPWpGaD
